Business
Soligenix Announces Participation at the Spartan Capital Investor Conference
Premier Event to Showcase Growth Companies and Foster High-Level Investor Engagement NEW YORK, N.Y. - (NewMediaWire) - October 29, 2024 - Soligenix, Inc.
About this update from Soligenix, Inc.
[{"type":"text","content":"Premier Event to Showcase Growth Companies and Foster High-Level Investor Engagement\nNEW YORK, N.Y. - (NewMediaWire) - October 29, 2024 - Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, is proud to announce its participation in Spartan Capital Securities, LLC's inaugural investor conference on November 4th at the prestigious Pierre Hotel in New York.\nChristopher J. Schaber, PhD, President and Chief Executive Officer of Soligenix, Inc. commented, \"We are pleased to be invited and to present at Spartan Capital's inaugural investor conference. This event provides an excellent platform to showcase our company and keep the key influencers in the capital markets apprised of our accomplishments and future plans as we move our rare disease pipeline forward.\"\nThe conference, organized in partnership with B2i Digital, a leading digital marketing firm specializing in investor communications, will feature presentations from over 30 carefully selected companies. The event will include panel discussions, one-on-one meetings, and networking sessions to maximize interactions between investors and presenters.\n\"We're privileged to welcome Soligenix, Inc. to this pivotal event and showcase their accomplishment on b2idigital.com and with our 950K+ sophisticated investor community across social media,\" added David Shapiro, CEO of B2i Digital.\nJohn D. Lowry, Founder and Chief Executive Officer of Spartan Capital Securities, LLC, stated, \"Our inaugural investor conference commemorates Spartan Capital's 17 years as a trusted leader in the capital markets. It underscores our commitment to building meaningful connections between client companies and our sophisticated investor base. The Pierre is an ideal venue for our clients to explore capital formation opportunities and strengthen relationships.\"\nFor more information about the conference and registration details, please visit Spartan Capital's conference page.\nAbout Soligenix, Inc.\nSoligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. Our Specialized BioTherapeutics business segment is developing and moving toward potenti...